Chargement en cours...
Impact of tumour size measurement inter-operator variability on model-based drug effect evaluation
PURPOSE: During oncology clinical trials, tumour size (TS) measurements are commonly used to monitor disease progression and to assess drug efficacy. We explored inter-operator variability within a subset of a phase III clinical trial conducted from August 1995 to February 1997 and its impact on dru...
Enregistré dans:
| Publié dans: | Cancer Chemother Pharmacol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer Berlin Heidelberg
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7125250/ https://ncbi.nlm.nih.gov/pubmed/32170415 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-020-04049-5 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|